Welcome to the International Society for Vaccines

The Paper of month

December, 2011
A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design
November, 2011
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
October, 2011
A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates
September, 2011
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
August, 2011
Vaccine-derived poliomyelitis 12 years after infection in Minnesota
July, 2011
Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil
June, 2011
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
May, 2011
Programming the magnitude and persistence of antibody responses with innate immunity
April, 2011
An Inactivated Cell-Culture Vaccine against Yellow Fever
March, 2011
Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection
February, 2011
Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males
January, 2011
Highly effective generic adjuvant systems for orphan or poverty-related vaccines